Mesothelioma News
Verified reporting on mesothelioma treatment, clinical trials, asbestos and talc litigation, and developments relevant to patients and families.
Follow H&S reporting on Google
Choose Humpleby & Strauss as a Preferred Source for mesothelioma news.
Preferred Source on Google ↗Latest reporting
November 11, 2026 · Asbestos litigation and occupational exposure
Texas Appeals Court Revives Mesothelioma Claims After Decades-Old Refinery Asbestos Exposure
A November 5 Texas appellate ruling reinstates refinery asbestos claims, upholds a gross-negligence finding, and modifies exemplary damages.
November 10, 2026 · Medical research and immunotherapy
New Mesothelioma Study Examines MTAP Loss and Response to Immunotherapy
A November 6 study links MTAP loss with immune features and higher immunotherapy response in one mesothelioma cohort, but clinical use requires further validation.
November 9, 2026 · Treatment and clinical trials
Mesothelioma Clinical Trial Expands Research Locations for Experimental ODM-212 and Immunotherapy Combination
Updated TEADCO trial listings identify expanded research locations; mesothelioma-cohort availability requires confirmation.
November 1, 2026 · Asbestos bankruptcy and litigation
Barretts Minerals Reports 1,051 Pending Talc Cases as $450 Million Trust Proposal Remains Unresolved
An October SEC filing reports 1,051 pending talc cases; the proposed trust remains unconfirmed.
October 29, 2026 · Symptom management and pleural disease
Mesothelioma and Trapped Lung: New Study Examines Surgery Versus Pleural Catheter for Breathing Difficulties
What the MesoTRAP study can—and cannot—tell patients about pleural catheters and surgery for trapped lung.
October 28, 2026 · Diagnosis and pathology
New Mesothelioma Diagnostic Test Launched by Roche: What Patients Should Know About BAP1 Testing
What Roche's new VENTANA BAP1 assay can contribute to mesothelioma diagnosis—and why retained BAP1 does not rule out the disease.
October 27, 2026 · Treatment and clinical trials
RSO-021 and Mesothelioma: What the Published Clinical Research Shows
What peer-reviewed Phase I research establishes about investigational RSO-021, and why newer conference figures require separate verification.
October 27, 2026 · Asbestos bankruptcy and litigation
New York Joins 20 Other Attorneys General in Supreme Court Filing Over Asbestos Bankruptcy
What the DBMP/CertainTeed petition means for mesothelioma claims, bankruptcy stays and possible future trust procedures.
Updated October 27, 2026 · Treatment and clinical trials
ISM6331: New Clinical Results Added to Our October 25 Report
August 14 data update: four responses among 22 response-evaluable mesothelioma patients, with the original study findings preserved.
October 24, 2026 · Mesothelioma compensation
Mesothelioma Compensation: Court Approves $535 Million Settlement in Whittaker Talc Bankruptcy
What the October 22 court ruling may mean for potential compensation claims involving historical talc products.
October 22, 2026 · Treatment and clinical trials
Mesothelioma Clinical Trial Tests MTAP-Targeted Treatment After Cancer Returns
Southampton enrolls its first local participant in SELECTmeso1; what MTAP testing and experimental targeted therapy mean for people with recurrent mesothelioma.
October 22, 2026 · Bankruptcy
Vanderbilt Bankruptcy: Court Approves Disclosure Statement, Sets December Confirmation Hearing
The plan is not confirmed. What the October 20 court order means and which procedural dates come next.
Research behind the reporting
Historical investigation — November 2, 2026: Tracing the Talc in Clubman examines mineral-source evidence, laboratory testing, and mesothelioma litigation across decades.
Our coverage is connected to primary records and the firm's permanent research library. Begin with the mesothelioma center, asbestos bankruptcy trusts, Vanderbilt case overview, and Resource Center.
Editorial approach
We identify publication dates, distinguish allegations and proposals from court rulings, and link to original documents when available. News articles provide dated updates; permanent research pages provide background and context. Our legal news is informational and is not individual legal advice. Read our existing editorial standards and research method for sourcing, uncertainty, and corrections principles.